streptokinas recombin tissu plasminogen activ rt-pa effect acut myocardi infarct recent trial patient myocardi infarct recombin tissue-typ plasminogen activ rt-pa streptokinas differ amount myocardi salvag mortal reduct incid complic find expect rt-pa effect streptokinas thrombolyt agent basi mistaken predict unfortun overemphasi inadequ surrog endpoint patenc reperfus rate minut start therapi patenc reperfus rate endpoint sever seriou limit first observ point time dynam process infus proper second singl view minut possibl subsequ reocclus hour treatment third imag minut reflect speed thrombolysi lysi pace clot lysi agent age thrombu fourth lysi minut minim relev myocardi salvag time frame infarct size hour symptom onset time reperfus fifth stabl state vessel patenc meaning mortal reduct stabil complet infarct such late last patenc critic compon open vessel principl explain part surviv benefit patient hour onset symptom evid rt-pa benefici effect surviv function plasminogen activ acut myocardi infarct evid patient rt-pa therapi show decreas incid complic streptokinas rel fibrinogen-spar attribut rt-pa poor predict valu angiogram ultim clinic advantag agent studi endpoint margin use treatment regimen mortal studi evid date indic streptokinas rt-pa equival valu surviv acut myocardi infarct conclus valid mortal studi 